Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1126/science.aay3638 |
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis | |
Christina Krienke; Laura Kolb; Elif Diken; Michael Streuber; Sarah Kirchhoff; Thomas Bukur; Özlem Akilli-Öztürk; Lena M. Kranz; Hendrik Berger; Jutta Petschenka; Mustafa Diken; Sebastian Kreiter; Nir Yogev; Ari Waisman; Katalin Karikó; Özlem Türeci; Ugur Sahin | |
2021-01-08 | |
发表期刊 | Science |
出版年 | 2021 |
英文摘要 | Autoimmune diseases, such as multiple sclerosis (MS), result from a breach of immunological self-tolerance and tissue damage by autoreactive T lymphocytes. Current treatments can cause systemic immune suppression and side effects such as increased risk of infections. Krienke et al. designed a messenger RNA vaccine strategy that lacks adjuvant activity and delivers MS autoantigens into lymphoid dendritic cells. This approach expands a distinct type of antigen-specific effector regulatory T cell that suppresses autoreactivity against targeted autoantigens and promotes bystander suppression of autoreactive T cells against other myelin-specific autoantigens. In mouse models of MS, the vaccine delayed the onset and reduced the severity of established disease without showing overt symptoms of general immune suppression. Science , this issue p. [145][1] The ability to control autoreactive T cells without inducing systemic immune suppression is the major goal for treatment of autoimmune diseases. The key challenge is the safe and efficient delivery of pharmaceutically well-defined antigens in a noninflammatory context. Here, we show that systemic delivery of nanoparticle-formulated 1 methylpseudouridine-modified messenger RNA (m1Ψ mRNA) coding for disease-related autoantigens results in antigen presentation on splenic CD11c+ antigen-presenting cells in the absence of costimulatory signals. In several mouse models of multiple sclerosis, the disease is suppressed by treatment with such m1Ψ mRNA. The treatment effect is associated with a reduction of effector T cells and the development of regulatory T cell (Treg cell) populations. Notably, these Treg cells execute strong bystander immunosuppression and thus improve disease induced by cognate and noncognate autoantigens. [1]: /lookup/doi/10.1126/science.aay3638 |
领域 | 气候变化 ; 资源环境 |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/310442 |
专题 | 气候变化 资源环境科学 |
推荐引用方式 GB/T 7714 | Christina Krienke,Laura Kolb,Elif Diken,et al. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis[J]. Science,2021. |
APA | Christina Krienke.,Laura Kolb.,Elif Diken.,Michael Streuber.,Sarah Kirchhoff.,...&Ugur Sahin.(2021).A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.Science. |
MLA | Christina Krienke,et al."A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis".Science (2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论